MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 27, 2005; DOI: 10.1124/mol.105.015925


0026-895X/05/6804-1162-1171$20.00
Mol Pharmacol 68:1162-1171, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.015925v1
68/4/1162    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gotti, C.
Right arrow Articles by Zoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gotti, C.
Right arrow Articles by Zoli, M.

Heterogeneity and Selective Targeting of Neuronal Nicotinic Acetylcholine Receptor (nAChR) Subtypes Expressed on Retinal Afferents of the Superior Colliculus and Lateral Geniculate Nucleus: Identification of a New Native nAChR Subtype {alpha}3{beta}2({alpha}5 or {beta}3) Enriched in Retinocollicular Afferents

Cecilia Gotti, Milena Moretti, Alessio Zanardi, Annalisa Gaimarri, Nicolas Champtiaux, Jean-Pierre Changeux, Paul Whiteaker, Michael J. Marks, Francesco Clementi, and Michele Zoli

CNR, Institute of Neuroscience, Cellular and Molecular Pharmacology, Department of Medical Pharmacology and Center of Excellence on Neurodegenerative Diseases, University of Milan, Milan, Italy (C.G., M.M., A.G., F.C.); Department of Biomedical Sciences, Section of Physiology, University of Modena and Reggio Emilia, Modena, Italy (A.Z., M.Z.); Laboratoire de Neurobiologie Moléculaire, Centre National de la Recherche Scientifique Unité de Recherche Associée 2182 "Récepteurs et Cognition", Institut Pasteur, Paris, France (N.C., J.-P.C.); and Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado (P.W., M.J.M.)

The activation of neuronal nicotinic acetylcholine receptors (nAChRs) has been implicated in the activity-dependent development and plasticity of retina and the refinement of retinal projections. Pharmacological and functional studies have also indicated that different presynaptic nAChRs can have a modulatory function in retinotectal synapses. We biochemically and pharmacologically identified the multiple nAChR subtypes expressed on retinal afferents of the superior colliculus (SC) and lateral geniculate nucleus (LGN). We found that the {alpha}6{beta}2* and {alpha}4(non{alpha}6){beta}2* nAChRs are the major receptor populations expressed in both SC and LGN. In addition, the LGN contains two minor populations of {alpha}2{alpha}6{beta}2* and {alpha}3{beta}2* subtypes, whereas the SC contains a relatively large population of a new native subtype, the {alpha}3{beta}2({alpha}5/{beta}3) nAChR. This subtype binds the {alpha}-conotoxin MII with an affinity 50 times lower than that of the native {alpha}6{beta}2* subtype. Studies of tissues obtained from eye-enucleated animals allowed the identification of nAChRs expressed by retinal afferents: in SC {alpha}6{beta}2*, {alpha}4{alpha}6{beta}2*, and {alpha}3{beta}2* (approximately 45, 35, and 20%, respectively), in LGN, {alpha}4{alpha}6{beta}2*, {alpha}6{beta}2*, {alpha}4{beta}2*, {alpha}2{alpha}6{beta}2*, and {alpha}3{beta}2* (approximately 40, 30, 20, 5, and 5%, respectively). In both regions, more than 50% of nAChRs were not expressed by retinal afferents and belonged to the {alpha}4{beta}2* (90%) or {alpha}4{alpha}5{beta}2* (10%) subtypes. Moreover, studies of the SC tissues obtained from wild-type and {alpha}4, {alpha}6, and {beta}3 knockout mice confirmed and extended the data obtained in rat tissue and allowed a comprehensive dissection of the composition of nAChR subtypes present in this retinorecipient area.


Received for publication June 21, 2005.

Accepted for publication July 27, 2005.

Address correspondence to: Dr. Cecilia Gotti, CNR, Institute of Neuroscience, Section of Cellular and Molecular Pharmacology Center, Department of Medical Pharmacology, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy. E-mail: c.gotti{at}in.cnr.it




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
I. Manfredi, A. D. Zani, L. Rampoldi, S. Pegorini, I. Bernascone, M. Moretti, C. Gotti, L. Croci, G. G. Consalez, L. Ferini-Strambi, et al.
Expression of mutant {beta}2 nicotinic receptors during development is crucial for epileptogenesis
Hum. Mol. Genet., March 15, 2009; 18(6): 1075 - 1088.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. R. Grady, M. Moretti, M. Zoli, M. J. Marks, A. Zanardi, L. Pucci, F. Clementi, and C. Gotti
Rodent Habenulo-Interpeduncular Pathway Expresses a Large Variety of Uncommon nAChR Subtypes, But Only the {alpha}3{beta}4 and {alpha}3{beta}3{beta}4 Subtypes Mediate Acetylcholine Release
J. Neurosci., February 18, 2009; 29(7): 2272 - 2282.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gotti, M. Moretti, N. M. Meinerz, F. Clementi, A. Gaimarri, A. C. Collins, and M. J. Marks
Partial Deletion of the Nicotinic Cholinergic Receptor {alpha}4 or {beta}2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of {alpha}4 and {beta}2 Subunits
Mol. Pharmacol., June 1, 2008; 73(6): 1796 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. M. Drenan, R. Nashmi, P. Imoukhuede, H. Just, S. McKinney, and H. A. Lester
Subcellular Trafficking, Pentameric Assembly, and Subunit Stoichiometry of Neuronal Nicotinic Acetylcholine Receptors Containing Fluorescently Labeled {alpha}6 and 3 Subunits
Mol. Pharmacol., January 1, 2008; 73(1): 27 - 41.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. C. Perry, D. Mao, A. B. Gold, J. M. McIntosh, J. C. Pezzullo, and K. J. Kellar
Chronic Nicotine Differentially Regulates {alpha}6- and beta3-Containing Nicotinic Cholinergic Receptors in Rat Brain
J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 306 - 315.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. Tumkosit, A. Kuryatov, J. Luo, and J. Lindstrom
beta3 Subunits Promote Expression and Nicotine-Induced Up-Regulation of Human Nicotinic {alpha}6* Nicotinic Acetylcholine Receptors Expressed in Transfected Cell Lines
Mol. Pharmacol., October 1, 2006; 70(4): 1358 - 1368.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. J. Marks, P. Whiteaker, and A. C. Collins
Deletion of the {alpha}7, beta2, or beta4 Nicotinic Receptor Subunit Genes Identifies Highly Expressed Subtypes with Relatively Low Affinity for [3H]Epibatidine
Mol. Pharmacol., September 1, 2006; 70(3): 947 - 959.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics